Skip to main content

Advertisement

SpringerLink
Log in

Nocturnal hemodialysis

  • Review Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

With the increasing number of patients with end stage renal disease comes an increasingly urgent need for renal replacement therapy that is both clinically effective and cost effective. This article explores some of the advantages of nocturnal hemodialysis as well as some of the barriers to its use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sheldon S. Independence in maintenance haemodialysis. Lancet. 1968; 1:520.

    Article  Google Scholar 

  2. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol. 1998;9:859–68.

    CAS  PubMed  Google Scholar 

  3. Uldall PR, Francoeur R, Ouwendyk M. Simplified nocturnal home hemodialysis. A new approach to renal replacement therapy. J Am Soc Nephrol. 1994;5:42.

    Google Scholar 

  4. Blagg CR. A brief history of home hemodialysis. Adv Renal Replace Ther. 1996;3:99–105.

    Article  CAS  Google Scholar 

  5. Suri R, Depner TA, et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis. 2003;42:S42–8.

    Article  Google Scholar 

  6. Pierratos A. New approaches to hemodialysis. Annu Rev Med. 2004;55:179–89.

    Article  CAS  PubMed  Google Scholar 

  7. United States Renal Data System—USRDS. 2003. Mortality and causes of death. http://www.usrds.org/2002/pdf/h.pdf.

  8. United States Renal Data System. Excerpts from USRDS 2005 Annual Data Report. U.S. Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 2006; 47(Suppl 1):S1.

    Google Scholar 

  9. O’Seaghdha CM, Foley RN. Septicemia, access, cardiovascular disease, and death in dialysis patients. Perit Dial Int. 2005;25(6):534–40.

    PubMed  Google Scholar 

  10. Buzello M, Tornig J, Faulhaber J, Ehmke H, et al. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol. 2003;14(2):311–6.

    Article  CAS  PubMed  Google Scholar 

  11. Bro S, Bentzon JF, Falk E, et al. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol. 2003;14(10):2466–74.

    Article  CAS  PubMed  Google Scholar 

  12. Yuen D, Pierratos A, Richardson RMA, Chan CT. The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplantation. 2006;21:1407–12.

    Article  Google Scholar 

  13. Ottonello L, Gnerre P, et al. Leptin as a Uremic Toxin Interferes with Neutrophil chemotaxis. J Am Soc Nephrol. 2004;15:2366–72.

    Article  CAS  PubMed  Google Scholar 

  14. Pierratos A, McFarlane P, Chan CT. Quotidian dialysis–update 2005. Curr Opin Nephrol Hypertens. 2005;14:119–24.

    Article  PubMed  Google Scholar 

  15. Pierratos A. Daily nocturnal home hemodialysis. Kidney International. 2004;65:1975–86.

    Article  PubMed  Google Scholar 

  16. Gotch FA. Is Kt/V urea a satisfactory measure for dosing the newer dialysis regimens? Semin Dial. 2001;14:15–7.

    Article  PubMed  Google Scholar 

  17. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–9.

    Article  PubMed  Google Scholar 

  18. Clark WR, Leypoldt JK, Henderson LW, et al. Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol. 1999;10:601–9.

    CAS  PubMed  Google Scholar 

  19. Raj DS, Ouwendyk M, Francoeur R, et al. B2-microglobulin kinetics in nocturnal hemodialysis. Nephrol Dial Transplant. 2000;15:58–64.

    Article  CAS  PubMed  Google Scholar 

  20. Mucsi I, Hercz G, Uldall R, et al. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int. 1998;53:1399–404.

    Article  CAS  PubMed  Google Scholar 

  21. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorous and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607–17.

    Article  CAS  PubMed  Google Scholar 

  22. Pierratos A, Hercz G, Sherrard DJ, et al. Calcium, phosphorous metabolism and bone pathology on long term nocturnal hemodialysis. J Am Soc Nephrol. 2001;12:274. (abstract).

    Google Scholar 

  23. Kim SJ, Goldstein M, Szabo T, et al. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis. Am J Kidney Dis. 2003;41:12.

    Article  Google Scholar 

  24. Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States AJKD. 2002;40(6):1202–10.

    PubMed  Google Scholar 

  25. Yeboah J, Crouse JR, et al. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults. The Cardiovascular Health Study. Circulation. 2004;109:613–9.

    Article  Google Scholar 

  26. Ghiadoni L, Cupisti A, et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol. 2004;17:512–9.

    CAS  PubMed  Google Scholar 

  27. Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, London G. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int. 2000;57:1091–9.

    Article  CAS  PubMed  Google Scholar 

  28. Passauer J, Pitrosch F, et al. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. JASN. 2005;16:959–65.

    Article  CAS  PubMed  Google Scholar 

  29. Chan CT, Harvey PJ, et al. Short-term blood pressure, noradrenergic and vascular effects of nocturnal home hemodialysis. Hypertension. 2003;42(5):925–31.

    Article  CAS  PubMed  Google Scholar 

  30. Lindsay RM. The London, Ontario, Daily/Nocturnal Hemodialysis Study. Semin Dial. 2004;17(2):85–91.

    Article  PubMed  Google Scholar 

  31. Culleton BF, Walsh M, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. JAMA. 2007;298(11):1291–9.

    Article  CAS  PubMed  Google Scholar 

  32. Chan CT, Notarius CF, et al. Improvement in exercise duration and capacity after conversion to nocturnal home haemodialysis. Nephrol Dial Transplant. 2007;22(11):3285–91.

    Article  PubMed  Google Scholar 

  33. Fong E, Bargman JM, et al. Cross-sectional comparison of quality of life and illness intrusiveness in patients who are treated with nocturnal home hemodialysis versus peritoneal dialysis. Clin J Am Soc Nephrol. 2007;2:1195–200.

    Article  PubMed  Google Scholar 

  34. Elder SJ, Pisoni RL, et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2008;23(3):998–1004.

    Article  PubMed  Google Scholar 

  35. Kocak H, Ly J, Chan CT. Improvement in open angle glaucoma by nocturnal home haemodialysis. Neph Dialy Transp. 2006;21(9):2647–9.

    Article  Google Scholar 

  36. Jassal SV, Devins GM, et al. Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study. Kidney Int. 2006;70(5):956–62.

    Article  CAS  PubMed  Google Scholar 

  37. Lynn KL, Buttimore J, Wells JE, et al. Long-term survival of arteriovenous fistulas in home hemodialysis patients. Ki dney International. 2004;65:1890–6.

    Article  Google Scholar 

  38. McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney International. 2002;62:2216–22.

    Article  PubMed  Google Scholar 

  39. Diaz-Buxo JA, Schlaeper C, VanValkenburgh D. Evolution of home hemodialysis monitoring systems. Hemodial Int. 2003;7:353–5.

    Article  PubMed  Google Scholar 

  40. Heidenheim AP, Leitch R, Kortas C, Lindsay RM. Patient monitoring in the London daily/nocturnal hemodialysis study. Am J Kidney Dis. 2003;42:61–5.

    Article  PubMed  Google Scholar 

  41. Rodriguez HJ, Domenici R, Diroll A, Goykhman I. Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line. Kidney International. 2005;68:854–61.

    Article  PubMed  Google Scholar 

  42. Jaeger JQ, Mehta RL. Assessment of Dry Weight in Hemodialysis: An Overview. J Am Soc Nephrol. 1999;10:392–403.

    CAS  PubMed  Google Scholar 

  43. Ayus JC, Mizani MR, et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol. 2005;16(9):2778–88.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. New Jersey Medical School, 185 South Orange Avenue, MSB I-512, Newark, NJ, 07103, USA

    Paramjit Kalirao & Joshua M. Kaplan

Authors
  1. Paramjit Kalirao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joshua M. Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joshua M. Kaplan.

About this article

Cite this article

Kalirao, P., Kaplan, J.M. Nocturnal hemodialysis. Clin Exp Nephrol 13, 257–262 (2009). https://doi.org/10.1007/s10157-008-0110-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-008-0110-1

Keywords

Search

Navigation